These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 11104939)

  • 41. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemistry and Toxicology of Major Bioactive Substances in
    Patocka J; Wu R; Nepovimova E; Valis M; Wu W; Kuca K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Poisoning with Coprinus atramentarius, a previously unknown hallucinogenic mushroom: report of two cases].
    Braclik M; Kucharz EJ; Kotulska A
    Pol Arch Med Wewn; 1998 Sep; 100(3):285-6. PubMed ID: 10335036
    [No Abstract]   [Full Text] [Related]  

  • 44. [The morphofunctional changes in the internal organs in the modelling of poisonings by psilocybine-containing mushrooms].
    Babakhanian RV; Ivanova GV; Kostyrko TA; Safraĭ AE; Iagmurov OD
    Sud Med Ekspert; 1999; 42(3):6-9. PubMed ID: 10396957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hallucinogenic fungi (Psylocibe). Part I. Characteristics, results of consumption, recognition].
    Janoszka J; Rymkiewicz A; Dobosz T
    Arch Med Sadowej Kryminol; 2005; 55(3):215-9. PubMed ID: 16320771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on psilocybin, a hallucinogenic drug from the Mexican mushroom Psilocybe mexicana].
    GNIRSS F
    Schweiz Arch Neurol Neurochir Psychiatr; 1959; 84():346-8. PubMed ID: 13850311
    [No Abstract]   [Full Text] [Related]  

  • 47. Morphological and chemical analysis of magic mushrooms in Japan.
    Tsujikawa K; Kanamori T; Iwata Y; Ohmae Y; Sugita R; Inoue H; Kishi T
    Forensic Sci Int; 2003 Dec; 138(1-3):85-90. PubMed ID: 14642723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hallucinogenic effect of 2 mushrooms of the genus Psilocybe from Czechoslovakia].
    Auert G; Dolezal V; Hausner M; Semerdzieva M
    Z Arztl Fortbild (Jena); 1980 Sep; 74(17):833-5. PubMed ID: 7192453
    [No Abstract]   [Full Text] [Related]  

  • 49. An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms.
    Casale JF
    J Forensic Sci; 1985 Jan; 30(1):247-50. PubMed ID: 4038992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].
    Schäfer AT
    Arch Kriminol; 2000; 205(1-2):30-6. PubMed ID: 10726173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The occurrence of psilocybin in Gymnopilus species.
    Hatfield GM; Valdes LJ
    Lloydia; 1978; 41(2):140-4. PubMed ID: 565861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychedelic fungus (Psilocybe sp.) authentication in a case of illegal drug traffic: sporological, molecular analysis and identification of the psychoactive substance.
    Solano J; Anabalón L; Figueroa S; Lizama C; Reyes LC; Gangitano D
    Sci Justice; 2019 Jan; 59(1):102-108. PubMed ID: 30654963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.
    Dodd S; Norman TR; Eyre HA; Stahl SM; Phillips A; Carvalho AF; Berk M
    CNS Spectr; 2022 Jul; ():1-11. PubMed ID: 35811423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hallucinogenic drugs in pre-Columbian Mesoamerican cultures.
    Carod-Artal FJ
    Neurologia; 2015; 30(1):42-9. PubMed ID: 21893367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Psilocybin - public available psychodysleptic].
    Dydak K; Śliwińska-Mossoń M; Milnerowicz H
    Postepy Hig Med Dosw (Online); 2015 Sep; 69():986-95. PubMed ID: 26400885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The problem of psilocybin mushroom abuse.
    Peden NR; Pringle SD; Crooks J
    Hum Toxicol; 1982 Oct; 1(4):417-24. PubMed ID: 7173927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.
    Strauss D; Ghosh S; Murray Z; Gryzenhout M
    3 Biotech; 2022 Dec; 12(12):339. PubMed ID: 36340802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pharmacology of psilocybin.
    Passie T; Seifert J; Schneider U; Emrich HM
    Addict Biol; 2002 Oct; 7(4):357-64. PubMed ID: 14578010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occurrence of psilocybin in various higher fungi from several European countries.
    Stijve T; Kuyper TW
    Planta Med; 1985 Oct; 51(5):385-7. PubMed ID: 17342589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.